Skip to main content

We help bring your science to life

"Inpart has enabled Lilly to standardize processes, enable more consistent data across the entire External Innovation community and place data more directly into the hands of business development leadership."

Senior VP, Corporate Business Development at Eli Lilly

Contact us
Read customer stories

500+ organizations around the world are already reinventing the way they
  • showcase their assets,
  • showcase academic research,
  • find partners,
  • find innovation,
  • do search & evaluation,
  • accelerate research commercialization,
  • invest in untapped science,
  • fuel their R&D pipeline,
  • do business development,
  • track partnering opportunities,
  • do due diligence,
  • achieve partnering excellence,
  • manage their alliances,
  • build insightful reporting,
  • bring science to life.

Poseidon LLC
Poseidon LLC
Kidney Research UK
Healx
Molecure
TScan Therapeutics
Ferring Pharmaceuticals
Ipsen
Novo Nordisk
Shadow Lake Group
Théa Open Innovation
Zambon
Eli Lilly and Company
UCB Pharma
Pierre Fabre
Servier
Procter & Gamble
Abbvie
Poseidon LLC
Poseidon LLC
Kidney Research UK
Healx
Molecure
TScan Therapeutics
Ferring Pharmaceuticals
Ipsen
Novo Nordisk
Shadow Lake Group
Théa Open Innovation
Zambon
Eli Lilly and Company
UCB Pharma
Pierre Fabre
Servier
Procter & Gamble
Abbvie

90% of the top 150 pharma companies use at least one of our solutions

Exclusive access to a vetted, global network of innovators

Become a part of the growing community of Inpart customers and connect with academics, researchers, scientists, and decision-makers worldwide - sourcing innovation and building impactful partnerships.

Get started
Learn more
  • Registered members in the network 20,000+
  • Biotech companies 4,000+
  • Opportunities for collaboration 9,000+
  • Universities and research institutes 2,600+
  • Open innovation campaigns executed 200+

Co-creating solutions tailored to your needs

Find a solution

At Inpart, our customers thrive with the support of dedicated Customer Success Managers and an in-house team of STEM experts - ensuring a seamless journey from day one.

Academic faculties/labs

Generate impact

Universities

Find industry partners

Biotechs

Scale up your partnering

Pharma

Achieve organizational excellence

Investors

Uncover your next unicorn

Event organizers

Supercharge your event

Other industries

Fuel your pipeline with innovation

Why our customers love Inpart

We find a lot of synergy with Inpart and have always seen them as a companion to what we want to achieve.
Rajika Perera, Co-founder & CEO at Poseidon LLC
The Inpart Team has a huge amount of expertise in creating efficient partnering processes. Thanks to them, we have improved and refined our processes and the way we work.
Senior Director, Head of External Innovation Europe & Asia at Ipsen
The entire process was very straightforward and well-organized, with excellent support from the Connect Campaigns team. From identifying our areas of interest to making introductions to potential partners.
Catherine Miner, Managing Partner at Shadow Lake Group
A dedicated Customer Success Manager has been a gamechanger. She's always happy to help, offer advice, and answer questions. We know that we can rely on her, she's like an extension of our team. It's such a refreshing change
Program Director at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
Inpart provides us with a convenient, centralized stream of funding and collaboration opportunities, helping our team showcase our institute's excellent research and expertise.
Program Director at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
Inpart showed us that we don't know our network as well as we thought we did! The professional and responsive team are a joy to work with and we would be happy to use them again.
Associate Director, Immunology Partnering at UCB Pharma
I wanted a solution for my Technology Scouting team that required minimal IT involvement. The BD and AM teams were already using Inpart and happy with it. I am very glad we also chose Inpart, it’s intuitive and easy-to-use.
Associate Vice President, FCT & External Technologies at Ferring Pharmaceuticals
The team's responsiveness and proactive communication made the experience seamless and ensured we stayed on track throughout the process.
Advanced Technology Manager, Global Lubricants Manufacturer
Thanks to Inpart, we started conversations with Johns Hopkins University, the University of Pittsburgh, and the University of California San Diego, our company is about to enter into a CDA with the University of Southern California and are waiting for a draft CDA from Vanderbilt University, as well.
Head of Partnering and Search, Global Pharmaceutical Company
We were looking for more innovative ways to find funding. Inpart helped us get a lot of feedback on our new asset, including interest from top 5 pharma companies. The feedback reassured us that we were on the right track and we could provide updates in real-time using the platform, instead of waiting for next year's conference.
Rajika Perera, CEO and Co-founder of Poseidon Laboratory
We are beginning to build new relationships and have had non-confidential discussions with some biotech submissions. We are also in contact with an academic submitter and may possibly have further discussions for a partnership.
Open Innovation team member, Global Pharmaceutical Company
Inpart has been really useful in terms of networking and progressing our technology's development. We are closer to market for specific applications of our technology because of the partnerships we have formed through Inpart.
Kirsty Smitten, CEO and Co-founder of MetalloBio
Inpart Connect is the best platform we've ever worked with. We've been subscribed since the start of 2018, and have received a range of useful introductions and feedback for our technologies from relevant companies in Europe and beyond.
Helga Kroschewski, Deputy Head of Technology Transfer, Medical University of Vienna
Connect Campaigns exposed us to broader range of opportunities from all over the world, and thus, helped us to identify and connect with new opportunities which we could not reach out by ourselves.
Open Innovation team member, Global Pharmaceutical Company
Inpart checked all the boxes. It's designed for biopharma business development, integrates with partnering conferences, and enables easy, professional reporting.
Catherine Miner, Managing Partner at Shadow Lake Group
Inpart Connect is our gateway to the universe of industry collaborations, a valuable partner whose contribution goes beyond marketing and facilitating discussions with the right people in industry. Inpart brings results and has become our strategic (plus not to mention fun) friend on the road of transferring new technologies to the development stage.
Tatiana Venkova, Licensing Associate at Fox Chase Cancer Centre
Inpart is built exactly for what we do, pharma partnering. It helps us work together as one company. We started with just the S&E department, then quickly scaled the solution to add more teams such as the drug delivery and digital health teams. With everything in one place, we collaborate better together.
Search & Evaluation Director at Novo Nordisk
I enjoy using Inpart Connect to easily access academic research from universities across the globe. Unlike other providers, Inpart offers personalized services to screen for early-stage innovation, specific to our research requirements, at a large number of associated universities! And amazingly, they do this free of charge.
Dieter Ziegler, Director, Ventures & Early Stage Collaborations at AbbVie

Case studies

  • Manufacturing Connect
    "Accelerating R&D pipeline for a global lubricants manufacturer"

    Accelerating R&D pipeline for a global lubricants manufacturer

    Scouting
  • Pharma Connect
    "Activating global science networks to identify novel targets in autoimmune diseases"

    Activating global science networks to identify novel targets in autoimmune diseases

    Scouting
  • Pharma Deal
    Novo Nordisk
    "Centralizing Novo Nordisk's scouting processes"

    Centralizing Novo Nordisk's scouting processes

    Search & Evaluation Business Development
  • University TTO Connect
    Durham University
    "Durham University commercializes research in crop science"

    Durham University commercializes research in crop science

    Out-Licensing
  • Advisory firm Deal
    Shadow Lake Group
    "How Shadow Lake Group tracks its partnering opportunities"

    How Shadow Lake Group tracks its partnering opportunities

    Business Development
  • Materials Connect
    "Identifying innovative solutions in materials science development"

    Identifying innovative solutions in materials science development

    Scouting
  • Pharma Deal
    Ferring Pharmaceuticals
    "Ferring's new process for external technology scouting"

    Ferring's new process for external technology scouting

    Search & Evaluation
  • Biotechnology Connect
    Poseidon LLC
    "How Poseidon LLC leverages global, year-round partnering"

    How Poseidon LLC leverages global, year-round partnering

    Out-Licensing
  • Pharma Deal
    Ipsen
    "Redefining Ipsen's external innovation model"

    Redefining Ipsen's external innovation model

    Search & Evaluation Business Development
  • University TTO Connect
    University of North Texas
    "University of North Texas optimizes its technology"

    University of North Texas optimizes its technology

    Out-Licensing
© 2025 Inpart. All rights reserved.
We help bring science to life.
Privacy policy Terms of use